Hidradenitis suppurativa trials in Italy

In Italy 9 Also abroad 73

6 of 9 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Where
Ancona, Catania, L'aquila, Milan, Naples, Perugia, Pisa, Rome, Rozzano
Age
18 years and over
People
600 worldwide
Run by
Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00
Phase 3Not yet taking people in Italy
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Where
Ancona, Brescia, Catania, Ferrara, Florence, Modena, Pisa, Rome, Rozzano, Turin
Age
18 years to 100 years
People
710 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07665437 · EU 2025-523259-72-00
Phase 2Taking people
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Where
Ancona, Brescia, Catania, Chieti Scalo, Ferrara, Milan, Pisa
Age
18 years and over
People
144 worldwide
Run by
Sanofi
See details and how to joinNCT07225569 · EU 2025-522695-83-00
Phase 2Active, not recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Where
Catania, Milan, Rome, Rozzano
Age
18 years and over
People
208 worldwide
Run by
Sanofi
See details and how to joinNCT07170917 · EU 2025-522333-61-00
Phase 3Enrolling by invitation
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
Where
Catania, Chieti, Cona, Florence, Milan, Modena, Naples, Perugia, Pisa, Roma, Rozzano, Torino, Torrette
Age
12 years and over
People
835 worldwide
Run by
MoonLake Immunotherapeutics AG
See details and how to joinNCT07007637
Phase 2Taking people
A Study of LAD191 in Adults With Hidradenitis Suppurativa
Where
Ferrara, Florence, Pisa, Torino
Age
18 years to 65 years
People
200 worldwide
Run by
Almirall, S.A.
See details and how to joinNCT07151937 · EU 2025-521293-34-00